BAMBI protein expressed in the liver negatively correlated with the body mass index [55], suggesting that body weight-related factors such as adiponectin, whose circulating levels are low in NAFLD patients [102,104], may regulate hepatic BAMBI levels. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.